Navigation Links
Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
Date:7/16/2008

SHAANXI, China, July 16 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio- pharmaceutical Technology Inc. (OTC Bulletin Board: HFGB) a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in China, announced on July 15 that it has established a strategic alliance with Premier Media Service Inc. of Mesa, Arizona. Premier will focus on corporate imaging and creating retail market awareness for the existing and new shareholder base.

Jing An Wang, CEO/President of Huifeng said, "We are pleased to be associated with a high-powered financial marketing company with the caliber of Premier. We believe Premier will help bring investor awareness to our stock and brand awareness for our products to the financial community. We believe Premier will aggressively and successfully introduce our unique company to the public markets, broker dealer associations, financial services sector and institutional investors of public companies while enhancing our brand name awareness."

Kelly Black, President and CEO of Premier Media Service Inc., said, "We are proud to work with Huifeng Bio-pharmaceuticals, we believe they have many innovative technologies to further progress plant extracts used by pharmaceutical companies to main stream natural products into pharmaceutical markets.'' Ms. Black went on to state, ''At Premier we look for companies to work with that are making dramatic changes in their market place and we are impressed with the high quality standards and unique market opportunities for Huifeng Bio- pharmaceutical as they serve a diverse domestic and international customer base.

About Huifeng Bio-Pharmaceutical Technology, Inc.

Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. Additional information about Huifeng can be found from their website, http://www.hfgb.cn .

About Premier Media Services, Inc. (PMSI)

Premier Media Services, Inc. is a full-service public relations consulting firm dedicated to providing broadcast news and financial marketing services. PMSI offers multi-faceted public and investor relations campaigns designed to maximize institutional and private investor awareness of companies traded on all major exchanges. PMSI produces a bi-monthly broadcast news show, as well as produces live CEO Interviews, conference filming, television commercials and other broadcast services through its wholly-owned subsidiary, Premier Stocks TV (PSTV) ( http://www.premierstocks.tv or http://www.hotchicksstockpicks.com ).

Forward-Looking Statement Notice: This press release includes "forward- looking statements" as defined by the Securities and Exchange Commission (the "SEC"). All statements, other than statements of historical fact, included in the press release that address activities, events or developments that the company believes or anticipates will or may occur in the future are forward- looking statements. These statements are based on certain assumptions made based on experience, expected future developments and other factors the company believes are appropriate under the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the company and may not materialize. Investors are cautioned that any such statements are not guarantees of future performance.

For more Information or questions please contact:

Premier Media Service

Office: +1-480-649-8224

Kelly Black, President

Email: kblack@premiermediaservice.com

Heather Kerwin

V.P .Investor Relations

Email: hkerwin@premiermediaservice.com

Dan Carlson

Primary Capital

Tel: +1-415-460-1165

Email: dcarlson@primaryllc.com


'/>"/>
SOURCE Huifeng Bio-pharmaceutical Technology Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poors Market Access Program
2. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
3. Huifeng Bio-Pharmaceutical (HFGB) Announces No Earthquake Related Damage to Facilities
4. Huifeng Bio-Pharmaceutical (HFGB) to Release First Quarter 2008 Earnings Results on May 15, 2008
5. Huifeng Bio-Pharmaceutical (HFGB) Announces 2007 Full Year Results
6. Sentry Enhances Offerings with Temperature-Controlled Custom Bio-Pharmaceutical Finishing Services
7. Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
8. Skystar Bio-Pharmaceutical Raises 2007 Revenue Guidance to $15.8 Million
9. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
10. BioWa and Medarex Announce License of BioWas COMPLEGENT(TM) Technology
11. Quintiles Named to Computerworld Magazines 100 Best Places to Work in Information Technology List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):